Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury

International Immunopharmacology

Volumn 9, Issue 10, 2009, Pages 1168-1174

  Krakauer, Teresa ^a   Buckley, Marilyn J ^a   Huzella, Louis M ^a   Alves, Derron A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Cytokines; Glucocorticoid; Lung; Shock; Superantigens

Indexed keywords

DEXAMETHASONE; INTERLEUKIN 2; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HISTOPATHOLOGY; HYPOTHERMIA; LUNG INJURY; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SURVIVAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DEXAMETHASONE; DRUG ADMINISTRATION ROUTES; ENTEROTOXINS; LUNG; MALE; MICE; MICE, INBRED C3H; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TIME FACTORS;

EID: 69249222604     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.06.004     Document Type: Article

References (39)

1. McCormick J.K., Yarwood J.M., and Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Ann Rev Microbiol 55 (2001) 77-104
2. Stevens D.L. The toxic shock syndromes. Infect Dis Clin North Am 10 (1996) 727-746
3. Kotzin B.L., Leung D.Y.M., Kappler J., and Marrack P.A. Superantigens and their potential role in human disease. Adv Immunol 54 (1993) 99-166
4. Choi Y., Kotzin B., Hernon L., Callahan J., Marrack P., and Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci USA 86 (1989) 8941-8945
5. Marrack P., and Kappler J. The staphylococcal enterotoxins and their relatives. Science 0248 (1990) 705-709
6. Proft T., and Fraser J.D. Bacterial superantigens. Clin Exp Immunol 133 (2003) 299-306
7. Schlievert P.M. Role of superantigens in human disease. J Infect Dis 167 (1993) 997-1002
8. Wieneke A., Roberts D., and Gilbert R.J. Staphylococcal food poisoning in the United Kingdom, 1969-1990. Epidemiol Infect 110 (1993) 519-531
9. Bergdoll M.S. Monkey feeding test for staphylococcal enterotoxin. Meth Enzymol 165 (1988) 324-333
10. Holmberg S.D., and Blake P.A. Staphylococcal food poisoning in the United States. New facts and old misconceptions. JAMA 251 (1984) 487-489
11. Madsen J.M. Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med 21 (2001) 593-605
12. Darenberg J., Soderquist B., Normark B.H., and Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis 38 (2004) 836-842
13. Mollick J.A., Chintagumpala M., Cook R.G., and Rich R.R. Staphylococcal exotoxin activation of T cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol 146 (1991) 463-468
14. Fleischer B., Schrezenmeier H., and Conradt P. T lymphocyte activation by staphylococcal enterotoxins: role of class II molecules and T cell surface structures. Cell Immunol 120 (1989) 92-101
15. Stiles B.G., Bavari S., Krakauer T., and Ulrich R.G. Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun 61 (1993) 5333-5338
16. Stone R.L., and Schlievert P.M. Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis 155 (1987) 682-689
17. Sarawar S.R., Blackman M.A., and Doherty P.C. Superantigen shock in mice with an inapparent viral infection. J Infect Dis 170 (1994) 1189-1194
18. Nagaki M., Muto Y., Ohnishi H., Yasuda S., Sano K., Naito T., et al. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106 (1994) 450-458
19. Chen J.Y., Qiao Y., Komisar J.L., Baze W.B., Hsu I.C., and Tseng J. Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun 62 (1994) 4626-4631
20. Dinges M.M., and Schlievert P.M. Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun 69 (2001) 7169-7172
21. Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 20 (1999) 163-173
22. Rajagopalan G., Iijima K., Singh M., Kita H., Patel R., and David C.S. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun 74 (2006) 1284-1296
23. DaSilva L., Welcher B., Ulrich R., Aman M., David C., and Bavari S. Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylocococal enterotoxins: a novel model for superantigen vaccines. J Infect Dis 185 (2002) 1754-1760
24. Yeung R.S., Penninger J.M., Kundig T., Khoo W., Ohashi P.S., Kroemer G., et al. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol 26 (1996) 1074-1082
25. Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model. Res Vet Sci 2009;86:241-247.
26. Annane D., Bellissant E., Bollaert P.E., Briegel J.B., Keh D., and Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480-489
27. Stiles B.G., Campbell Y.G., Castle R.M., and Grove S.A. Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1. Infect Immun 67 (1999) 1521-1525
28. Roy C.J., Warfield K.L., Welcher B.C., Gonzales R.F., Larsen T., Hanson J., et al. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun 73 (2005) 2452-2460
29. Tang B.M., Craig J.C., Eslick G.D., Seppelt I., and McLean A.S. Use of corticosteriods in acute respiratory distress syndrome; a systemic review and meta analysis. Crit Care Med 37 (2009) 1594-1603
30. Krakauer T. Interleukin-8 production by human monocytic cells in response to staphylococcal exotoxins is direct and independent of interleukin-1 and tumor necrosis factor-α. J Infect Dis 178 (1998) 573-577
31. Krakauer T. The induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline. J Leukco Biol 66 (1999) 158-164
32. Krakauer T., Vilcek J., and Oppenheim J.J. TNF family cytokines, chemokines and other pro- or anti-inflammatory cytokines. In: Paul W. (Ed). Fundamental immunology. 4th Edition (1998), Raven Press 783-819
33. Rosenberg H.F., and Demachowske J.B. Pneumonia virus of mice: severe respiratory infection in a natural host. Immunol Lett 118 (2008) 6-12
34. Bonville C.A., Lau V.K., DeLeon J.M., Gao J.L., Easton A.J., Rosenberg H.F., and Domachowske J.B. Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo. J Virol 78 (2004) 7984-7989
35. Glass W.G., Subbarao K., Murphy B., and Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 173 (2004) 4030-4039
36. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1997 through 2000. N Engl J Med 348 (2003) 1546-1554
37. Warren H.S., Suffredini A.F., Eichacker P.Q., and Munford R.S. Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347 (2002) 1027-1030
38. Huang K.J., Su I.J., Theron M., Wu Y.C., Lai S.K., Liu C.C., and Lei H.Y. An interferon-gamma-related cytokine storm in SARS patients. I Med Virol (2005) 185-194
39. Chien J.Y., Hsueh P.R., Cheng W.C., Yu C.J., and Yang P.C. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome. Respirology 11 (2006) 715-722